Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

Fig. 1

The expression of ACSL4 is upregulated in CHOL. (A) The expression of ACSL4 in pan cancers from TCGA database was analyzed by TIMER2.0. (B-D) The level of ACSL4 is upregulated in CHOL tissues compared with normal tissues in TCGA-CHOL, GSE107943, GSE76956 datasets. (E) Western blotting was used to detect the protein level of ACSL4 in 6 pairs of CHOL tumor tissues (T) and their paired normal tissues (N). (F) The mRNA level of ACSL4 in 40 pairs of CHOL tissues and their paired normal tissues. (G) The expression of ACSL4 in CHOL tissue was measured by IHC staining from HPA database

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us